An effective agent for the treatment and/or prevention of Alzheimer's disease (AD) is needed due to the number of patients in the acute curve. In our research program to investigate effective agents for AD, we focused on crude drugs which consisted of incense sticks widely used in Asian countries including Japan. We selected 9 drugs as "aromatic" crude drugs and 2 as basal crude drugs. Among the samples tested, the essential oil obtained from the leaf of Cryptomeria japonica showed the most potent anti-acetylcholinesterase activity with 64.8% of inhibition at 100 μg/mL. In addition, no sample showed significant inhibition against β-secretase. From these results, the crude drugs selected in this study may be effective for AD therapy rather than prevention. The active principles of anti-acetylcholinesterase were investigated by activity-guided fractionation, and kaur-16-ene, nezukol and ferruginol were successfully identified, the IC 50 values were 640, 300 and 95 µM, respectively. Kaur-16-ene and nezukol inhibited acetylcholinesterase in the mixed type mode, while ferruginol inhibited it in the competitive mode. In addition, nezukol and ferruginol showed anti-butyrylcholinesterase activity, the IC 50 values were 155 and 22 μM, respectively. We also focused on the heartwood of Chamaecyparis obtusa, since this tree has been used as a building material for the heartwood of C. japonica. Ethyl acetate extract of C. obtusa showed anti-acetylcholinesterase activity of 37.7% inhibition at 100 μg/mL. The active principle was determined to be (-)-hinokinin by activity-guided fractionation and the IC 50 value was 176 μM. These results suggest that the leaf of C. japonica and heartwood of C. obtusa may be suitable agents for AD therapy when administered through the nasal system as an aroma supplement.
The increase in dementia patients shows a steep curve and almost 20% will suffer from dementia in the year 2025. The disease leads to a poor quality of life since there is no effective therapeutic agent. From this perspective, we have focused on the prevention of dementia, especially Alzheimer's disease (AD), utilizing a screening assay based on inhibition of β-secretase as an indicator. In previous reports, we successfully discovered effective agents from the screening of spices and herbs collected from natural plant resources [1, 2] . We found that extracts from turmeric (rhizome of Curcuma longa), curry leaf (leaf of Murraya koenigii), long pepper (fruit of Piper longum), cardamom (seed of Elettaria cardamomum), cinnamon (cortex of Cinnamomum zeylanicum), betel (leaf of Piper betle), white turmeric (rhizome of Curcuma zedoaria), aromatic ginger (rhizome of Kaempferia galanga) and sesame seed (seed of Sesamum indicum) possessed inhibitory activities against β-secretase and their active principles were disclosed. In addition, the therapeutic target of AD has focused on inhibition of acetylcholinesterase. We have screened spices and herbs for inhibition of acetylcholinesterase and found that the extract from white turmeric showed moderate activity and revealed its active principle as a flavonol glycoside, afzelin [3] .
These facts prompted us to screen for anti-acetylcholinesterase and anti-β-secretase agents using natural plant resources. We focused on "aromatic crude drugs" since various volatile compounds possess anti-acetylcholinesterase activity from previous report [4] . For the screening resources, we selected ingredients from incense sticks. Incense sticks consist of "aromatic crude drugs" and basal materials. From the aromatic crude drugs, cinnamon (bark of Cinnamomum cassia, CC), turmeric (rhizome of Curcuma longa, CL), clove (bud of Syzygium aromaticum, SAR), benzoin (resin of Styrax benzoin, SB), fenugreek (seed of Trigonella foenumgraecum, TF), patchouli (airy part of Pogostemon cablin, PC), star anise (fruit of Illicium verum, IV), sandalwood (stem of Santalum album, SAL), and frankincense (resin of Boswellia sp., BS) were selected. Cedar leaf (leaf of Cryptomeria japonica, CJ) and heartwood of Machilus thunbergii (MT) were selected from the basal material. The inhibitory activities of the extracts and the determination of the active principles are discussed in this report.
Essential oil was obtained by steam distillation according to the method described in the Japanese Pharmacopeia. Anti-acetylcholinesterase activities are shown in Table 1 . The data from turmeric, cinnamon fenugreek and clove were already investigated and reported in previous reports [1, 2] . However, the data were obtained again to compare potency with the other samples used in this study. Among the extracts from the aromatic materials, PC extract showed the most potent activity as 31.7% of inhibition at 100 µg/mL. CL and BS extracts also showed moderate activity as 26.4 and 24.4% of inhibition, respectively. The determination of the active principle from PC extract was unsuccessful due to the low yield (0.7%) from the raw material. Surprisingly, CJ extract, a basal ingredient of incense sticks, showed the most potent activity as 64.8% of inhibition at 100 µg/mL. The cedar tree, the most common tree in Japan, is mainly used as a building material and has a typical aroma in the stem and leaf. Therefore, an aromatic ingredient may be responsible for the anti-acetylcholinesterase activity.
Inhibitory activities against β-secretase were investigated and the results are shown in Table 2 . Among the samples tested, IV extract showed the most potent activity as 21.6% of inhibition at 100 µg/mL. Interestingly, CJ extract has no anti-β-secretase at the tested concentration. CJ extract may be effective as a therapeutic agent for AD, but not for preventive purposes. Each value represents the mean ± S.D. of triplicates. Inhibitor is Lys-Thr-Glu-Glu-Ile-
NPC Natural Product Communications
(3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid]. Significant difference from the control at **: P<0.01.
We focused on the CJ extract to investigate its active principle since it possessed high anti-acetylcholinesterase activity. In order to purify the active compound with activity guidance, an efficient extraction method using a low polar solvent should be used. We applied hexane, ethyl acetate and methanol for the extraction and hexane extraction was the most efficient, as shown in Table 3 . From these results we have decided to investigate active principles from hexane extract which likely contains the same active principle in steam distillation extract used in the screening study. Activityguided purification of the active principle using various liquid chromatographs led to the isolation of kaur-16-ene [5, 6] , nezukol [7] and ferruginol [8] (Figure 1 ). Anti-acetylcholinesterase activities (IC 50 ) of kaur-16-ene, nezukol and ferruginol were 640, 300 and 95 µM, respectively. The activity of ferruginol was already reported [9] while the activities of kaur-16-ene and nezukol are reported for the first time. Thus, we successfully determined a part of active principles for anti-acetylcholinesterase. The modes of action were investigated for the three compounds. Kaur-16-ene and nezukol showed mixed-type inhibition while ferruginol showed competitive inhibition against acetylcholinesterase ( Figure 2 ). This is the first report to reveal the mode of inhibition of ferruginol. The mode of action is useful information for structure-activity relationship studies. Donepezil, a potent acetylcholinesterase inhibitor used as medicine, is known to possess mixed type inhibition [10] . Thus, kaur-16-ene and nezukol may be suitable lead compounds for the development of potent inhibitors as medicines. From the therapeutic aspect of AD, inhibition of butyrylcholinesterase is another important target [11] . In late stage AD, butyrylcholinesterase is known as a dominant enzyme for degradation of acetylcholine. Thus, an agent possessing inhibitory activities against both enzymes would be a promising candidate. The inhibitory activities of kaur-16-ene, nezukol and ferruginol against butyrylcholinesterase were investigated and their IC 50 values were >300, 155 and 22 μM, respectively. Nezukol and ferruginol possessed both acetylcholinesterase and butyrylcholinesterase inhibitory activities and may be promising candidates for a novel anti-cholinesterase agent. The mode of actions for nezukol and ferruginol were determined as competitive inhibition according to Lineweaver-Burk plot analyses ( Figure 3 ).
These results suggest that CJ extract has a mixture of acetylcholinesterase and butyrylcholinesterase inhibitors, which act competitively and non-competitively. This may be an advantage for AD therapy. However, the activities are relatively low compared to medicinal compounds. Therefore, repetitive transnasal administration of CJ extract may be a candidate for alternative therapy or prevention of AD. The CJ extract results prompted us to extend the research on Chamaecyparis obtusa, a tree like C. japonica, used for building structures in Japan. The typical aroma from the heartwood is recognized as providing a relaxing effect. n-Hexane, ethyl acetate and methanol extracts were prepared from the heartwood of C. obtusa and anti-acetylcholinesterase activities were tested. Results are shown in Table 4 . Ethyl acetate extract showed the most potent activity among the extracts tested with 37.7% inhibition at 100 μg/mL. The ethyl acetate fraction was further subjected to solvent partition using butanol/water system. The butanol fraction showed higher activity than the water fraction of 41.1% inhibition at 100 μg/mL, which is the same potency as the ethyl acetate extract. The concentration of active principle was unsuccessful. However, polar impurities may be removed. The butanol fraction was further purified with reversed phase column chromatography and preparative HPLC to isolate (-)-hinokinin. (-)-Hinokinin showed an IC 50 of 176 μM. (-)-Hinokinin is a lignan which possesses multi-functions such as anti-cancer, a genotoxicity preventive effect, and modulatory effects on human monoamine and GABA transporter activities [12, 13] . This is the first report to reveal the anti-acetylcholinesterase activity of (-)-hinokinin. In this report, we showed the anti-acetylcholinesterase activities of extracts obtained from various "aromatic crude drugs" and basal materials, which are the ingredients of incense sticks used in Japan. We successfully found that CJ extract showed the most potent activity among the extracts tested. The active principles were revealed as diterpene compounds, kaur-16-ene, nezukol and ferruginol. In addition, the anti-butyrylcholinesterase activities and modes of action were investigated to show that CJ extract might be a suitable agent for the therapy and prevention of AD via repetitive transnasal administration. Furthermore, we focused on extracts from the heartwood of C. obtusa, which is used as a building material in Japan. The ethyl acetate extract showed most antiacetylcholinesterase activity among the extracts tested and revealed one of the active principles as (-)-hinokinin. This is the first report to show the anti-acetylcholinesterase activities of kaur-16-ene, nezukol and (-)-hinokinin and the anti-butyrylcholinesterase activities of kaur-16-ene and nezukol. The repetitive transnasal administration of kaur-16-ene, nezukol may be a good treatment for AD. From these results, it was successful to search the ingredients of incense stick for exploring a new remedy for AD. Moreover, the heartwood of C. obtusa was inspired from the result that the leaf of CJ possessed high potency on anti-acetylcholinesterase.
Experimental
Materials: Cinnamomum cassia, Illicium verum, Curcuma longa, Trigonella foenum-graecum, Syzygium aromaticum, Pogostemon cablin, Boswellia sp. were purchased from Tochimoto Tenkaido Co., Ltd. Styrax benzoin and Santalum album were purchased from Houzukien (Osaka, Japan). Cryptomeria japonica and Machilus thunbergii were provided from Maechu Co., Ltd. Chamaecyparis obtusa was obtained from the Nara campus of Kindai University (Nara, Japan).
Preparation of extracts (essential oil) for primary screening:
Steam distillation samples were prepared according to the quantitative method for essential oil described in the Japanese Pharmacopeia. Materials (50 g) were provided to the extraction. Xylene was used to trap essential oil from distillation and was removed by rotary evaporator to obtain crude essential oil for the screening assay. The yields of essential oil were CC-ext; 0.6%, SB-ext; 4.0%, IV-ext; 10.9%, CL-ext; 0.3%, TF-ext; 0.6%, SALext; 5.9%, SAR-ext; 23.6%, PC-ext; 0.7%, BS-ext; 1.6%, CJ-ext; 1.0% and MT-ext; 0.1%.
Inhibitory assay for acetyl-and butyrylcholinesterase:
Inhibitory activities against acetyl-and butyrylcholinesterase were evaluated according to the method previously reported [14] . Inhibitory assay for β-secretase: Inhibitory activities against β-secretase were evaluated according to the method previously reported [1] .
Preparation of extracts and purification of active principles from C. japonica: n-Hexane extract of C. japonica was prepared by immersing 100 g of the pulverized sample with 1000 mL of n-hexane at room temperature for 2 hrs. The suspension was filtered and filtrate obtained. The residue was extracted in the same manner as the obtained filtrate. The combined filtrate was evaporated to obtain n-hexane extract at a 5.0% yield. The ethyl acetate and methanol extracts were prepared in the same manner as n-hexane extract. The yields were 5.3 (ethyl acetate extract) and 5.5% (methanol extract). The n-hexane extract (5 g) was subjected to silicic acid column chromatography (silica gel 60, Merck, 5.0 i.d. x 32 cm) using n-hexane/ethyl acetate (50:1), (20:1), (10:1) and (2:1) mixtures as eluents to obtain 9 fractions (Fr. 1~9). The active Fr. 1 (n-hexane/ethyl acetate (50:1), 453 mg) was then subjected to reversed phase preparative HPLC column chromatography in the following conditions, column; YMC-Pack ODS-A (10 i.d. x 250 mm), column temperature; 40°C, mobile phase; water/acetonitrile (1:9), flow rate; 10 mL/min, detection; UV 254 nm to obtain compound 1 (11.9 mg) as clear amorphous powder. The active Fr. 2 (hexane/ethyl acetate (20:1), 770 mg) was subjected to the same HPLC conditions as compound 1 to obtain compound 2 (15.6 mg) as yellowish amorphous powder. The active Fr. 3 (hexane/ethyl acetate (20:1), 620 mg) was subjected to silicic acid column chromatography to obtain 7 fractions (Fr. 3-1~7) using n-hexane, n-hexane/ethyl acetate (50:1), (10:1) and ethyl acetate as eluents. Fr. 3-2 (n-hexane/ethyl acetate (50:1), 149.3 mg) was further fractionated with preparative HPLC in the following conditions, column; YMC-Pack ODS-A (10 i.d. x 250 mm), column temperature; 40°C, mobile phase; water/acetonitrile (1:19), flow rate; 10 mL/min, detection; UV 254 nm to obtain compound 3 (19.2 mg) as clear amorphous powder.
Preparation of extracts and purification of the active principle from C. obtusa: Heartwood of C. obtusa (2 kg) was cut into chips and immersed in n-haxane (20 L) for 2 hours at room temperature. The suspension was filtered and filtrate obtained. Extraction was repeated using the residue and two filtrates were combined and evaporated to give hexane extract at 0.4% yield. Ethyl acetate (2 L) was added to the n-hexane extract residue, and extracted in the same manner as the n-hexane extract to give ethyl acetate extract at 0.4% yield. Methanol (2 l) was added to the ethyl acetate extract residue, and extracted in the same manner as the n-hexane extract to give methanol extract at 1.7% yield.
Ethyl acetate extract was subjected to solvent partitioning using butanol/water (500 mL each) system. The butanol layer was removed and 500 mL of butanol added to the water layer. A butanol layer was obtained and the two butanol layers were combined. Each solvent was evaporated to give butanol and water fractions at 85.8 and 1.3% yields, respectively. The butanol fraction (425 mg) was subjected to reversed phased column chromatography (75C 18 -OPN, Nacalai Tesque, Kyoto, Japan, 3.1 i.d. x 15 cm) using methanol/water (1:9), (3:7), (1:1), (7:3) and (1:0) as mobile phased to give 6 fractions (Fr. 1~6). The active Fr. 4 (171 mg) was further fractionated with preparative HPLC in the following conditions, column; Waters SunFire (10 i.d. x 250 mm), column temperature; ambient, mobile phase; water/acetonitrile (4:1), flow rate; 5 mL/min, detection; UV 254 nm to give compound 4 (26.2 mg).
Structural elucidation of compound 1~4:The chemical structures of compounds 1 and 2 were determined with GC-MS analysis using Wiley7n and NIST08 library searches as kaur-16-ene and nezukol, respectively. The chemical structures of 3 and 4 were determined with NMR spectra as ferruginol and (-)-hinokinin, respectively [9, 15] . The stereochemistry of (-)-hinokinin was determined from the optical rotation data [15] .
Statistical analysis: All data were analyzed statistically using Statcel3 software (The Publisher OMS Ltd., Tokorozawa, Japan). One-way analysis of variance was performed and Bonferroni/Dunn algorithm was utilized to detect significant differences at P<0.01 and P<0.05.
